169 related articles for article (PubMed ID: 31680977)
1. Growth Inhibitory Activity of
Pineau RM; Hanson SE; Lyles JT; Quave CL
Front Pharmacol; 2019; 10():1206. PubMed ID: 31680977
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Anti-Acne Potential of Impepho [
De Canha MN; Komarnytsky S; Langhansova L; Lall N
Front Pharmacol; 2019; 10():1559. PubMed ID: 32082144
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Antibacterial and Anti-Inflammatory Activity of
Dell'Annunziata F; Cometa S; Della Marca R; Busto F; Folliero V; Franci G; Galdiero M; De Giglio E; De Filippis A
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145700
[No Abstract] [Full Text] [Related]
4. Antimicrobial Activity of
Joo JH; Han MH; Kim JI; Kim JE; Jung KH; Oh HS; Chung YS; An HJ; Lee JD; Moon GS; Lee HY
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500424
[TBL] [Abstract][Full Text] [Related]
5. [Phylotyping and Determining the Antimicrobial Susceptibility of Cutibacterium acnes Isolated from Patients with Acne Vulgaris].
Özel Kaya N; Usta İ; Demirçay ZÖ; Ülger Toprak N
Mikrobiyol Bul; 2021 Oct; 55(4):465-479. PubMed ID: 34666649
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Biofilm-Forming Ability and Antibiotic Resistance of
Ruchiatan K; Rizqandaru T; Satjamanggala PR; Tache N; Cahyadi AI; Rezano A; Gunawan H; Sutedja EK; Dwiyana RF; Hidayah RMN; Achdiat PA; Sutedja E; Suwarsa O; Hindritiani R
Clin Cosmet Investig Dermatol; 2023; 16():2457-2465. PubMed ID: 37719934
[TBL] [Abstract][Full Text] [Related]
7. Anti-Acne Activity of Italian Medicinal Plants Used for Skin Infection.
Nelson K; Lyles JT; Li T; Saitta A; Addie-Noye E; Tyler P; Quave CL
Front Pharmacol; 2016; 7():425. PubMed ID: 27891094
[No Abstract] [Full Text] [Related]
8.
Bronnec V; Eilers H; Jahns AC; Omer H; Alexeyev OA
Front Cell Infect Microbiol; 2021; 11():809792. PubMed ID: 35155271
[TBL] [Abstract][Full Text] [Related]
9.
Sitthichai P; Chanpirom S; Maneerat T; Charoensup R; Tree-Udom T; Pintathong P; Laphookhieo S; Sripisut T
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889274
[No Abstract] [Full Text] [Related]
10. Efficacy of two plant extracts against acne vulgaris: Initial results of microbiological tests and cell culture studies.
Kılıç S; Okullu SÖ; Kurt Ö; Sevinç H; Dündar C; Altınordu F; Türkoğlu M
J Cosmet Dermatol; 2019 Aug; 18(4):1061-1065. PubMed ID: 30414245
[TBL] [Abstract][Full Text] [Related]
11. Development of skin sebum medium and inhibition of lipase activity in
Nakase K; Momose M; Yukawa T; Nakaminami H
Access Microbiol; 2022; 4(10):acmi000397. PubMed ID: 36415741
[No Abstract] [Full Text] [Related]
12. Heat-treated Pediococcus acidilactici LM1013-mediated inhibition of biofilm formation by Cutibacterium acnes and its application in acne vulgaris: A single-arm clinical trial.
Bae WY; Jung WH; Lee YJ; Shin SL; An YK; Kim TR; Sohn M
J Cosmet Dermatol; 2023 Nov; 22(11):3125-3134. PubMed ID: 37177837
[TBL] [Abstract][Full Text] [Related]
13. The Anticancer Agent 3,3'-Diindolylmethane Inhibits Multispecies Biofilm Formation by Acne-Causing Bacteria and Candida albicans.
Kim YG; Lee JH; Park S; Lee J
Microbiol Spectr; 2022 Feb; 10(1):e0205621. PubMed ID: 35107361
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
[TBL] [Abstract][Full Text] [Related]
15. In Vitro and In Vivo Screening of Wild Bitter Melon Leaf for Anti-Inflammatory Activity against
Chuang LT; Shih YH; Huang WC; Lin LC; Hsu C; Chyuan JH; Tsai TH; Tsai PJ
Molecules; 2020 Sep; 25(18):. PubMed ID: 32961947
[No Abstract] [Full Text] [Related]
16. Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes.
Koyanagi S; Koizumi J; Nakase K; Hayashi N; Horiuchi Y; Watanabe K; Asai T; Yamazaki A; Nakazaki E; Nakaminami H
J Dermatol; 2023 Jun; 50(6):793-799. PubMed ID: 36880295
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in understanding
Platsidaki E; Dessinioti C
F1000Res; 2018; 7():. PubMed ID: 30613388
[TBL] [Abstract][Full Text] [Related]
18. Propionibacterium (Cutibacterium) acnes Bacteriophage Therapy in Acne: Current Evidence and Future Perspectives.
Castillo DE; Nanda S; Keri JE
Dermatol Ther (Heidelb); 2019 Mar; 9(1):19-31. PubMed ID: 30539425
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of doxycycline low-susceptible Cutibacterium acnes isolated from acne patients in Japan caused by antimicrobial use and diversification of tetracycline resistance factors.
Aoki S; Nakase K; Hayashi N; Nakaminami H; Noguchi N
J Dermatol; 2021 Sep; 48(9):1365-1371. PubMed ID: 33998707
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial and anti-inflammatory effects of Syzygium jambos L. (Alston) and isolated compounds on acne vulgaris.
Sharma R; Kishore N; Hussein A; Lall N
BMC Complement Altern Med; 2013 Oct; 13():292. PubMed ID: 24168697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
